This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.
Generated Narrative: MedicationDispense meddisp0306
status: in-progress
Reference |
alemtuzumab 10 MG/ML [Lemtrada] |
subject: Donald Duck
Actor |
Practitioner Rob van den Berk (official) |
authorizingPrescription: MedicationRequest: identifier = http://www.bmc.nl/portal/prescriptions#12345689 (use: official, ); status = completed; intent = order; authoredOn = 2015-01-15
type: Daily Fill
quantity: 5(unit 415818006 from http://snomed.info/sct) (Details: SNOMED CT code415818006 = 'Vial')
daysSupply: 7 Day (Details: UCUM coded = 'd')
whenPrepared: 2015-01-15T10:20:00Z
dosageInstruction
sequence: 1
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Calculated 3 mg (Details: UCUM codemg = 'mg')
dosageInstruction
sequence: 2
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Calculated 10 mg (Details: UCUM codemg = 'mg')
dosageInstruction
sequence: 3
text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk
additionalInstruction: Rapidly increase dose until tolerated, Administer on alternate days
timing: Duration 12weeks , 3 per 1 weeks
route: Intravenous route
method: Inject - dosing instruction imperative (qualifier value)
DoseAndRates
Type Dose[x] Calculated 30 mg (Details: UCUM codemg = 'mg')
Generated Narrative: Medication #med0303
code: alemtuzumab 10 MG/ML [Lemtrada]
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.